{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:16:41Z","timestamp":1791299801186,"version":"4.1.0"},"reference-count":49,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2017,7,3]]},"DOI":"10.1080\/13696998.2017.1302946","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T09:20:01Z","timestamp":1488792001000},"page":"678-686","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":26,"title":["Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat <i>Clostridium difficile<\/i> infection in France"],"prefix":"10.1080","volume":"20","author":[{"given":"Maureen","family":"Watt","sequence":"first","affiliation":[{"name":"Health Economics and Outcomes Research, Astellas Pharma EMEA, Chertsey, UK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Dinh","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine Aigu\u00eb Sp\u00e9cialis\u00e9e, Hopital Raymond Poincar\u00e9, Garches, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Le Monnier","sequence":"additional","affiliation":[{"name":"Microbiologie Clinique, Groupe Hospitalier Paris Saint-Joseph, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Tilleul","sequence":"additional","affiliation":[{"name":"Pharmacie \u00e0 Usage Int\u00e9rieur, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,3,16]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00127-14"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408913"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1086\/651706"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2012.02.004"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1086\/519265"},{"key":"CIT0006","doi-asserted-by":"crossref","unstructured":"Debast SB, Bauer MP, Kuijper EJ; European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 2014;20(Suppl 2):1-26","DOI":"10.1111\/1469-0691.12418"},{"key":"CIT0007","first-page":"S103","volume-title":"Clin Microbiol Infect","volume":"14","author":"Bouza E","year":"2008"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907635"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0910812"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.5899"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2011.59"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1159\/000351757"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.3.324"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis356"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir404"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12064"},{"key":"CIT0017","unstructured":"Escobar GJ, Baker M, Li SX, et\u00a0al. Clinical and economic burden of recurrent Clostridium difficile infections - a 10-year retrospective large database analysis. ICAAC, Washington DC, September 5\u20139, 2014 [Abstract K-362]"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-015-0810-x"},{"key":"CIT0019","first-page":"41","volume":"6","author":"Chaparro-Rojas F","year":"2013","journal-title":"Infect Drug Resist"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.042010-0"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis338"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70374-7"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku261"},{"key":"CIT0024","unstructured":"L\u2019Assurance Maladie 2015. Base des m\u00e9dicaments \u00e0 code UCD, February 1, 2012. http:\/\/www.ameli.fr\/professionnels-de-sante\/directeurs-d-etablissements-de-sante\/codage\/medicaments\/base-des-medicaments-a-code-ucd.php. Accessed June 15, 2015"},{"key":"CIT0025","unstructured":"ISPOR Global Health Care Systems Road Map 2009. http:\/\/www.ispor.org\/htaroadmaps\/france.asp#1. Accessed June 15, 2015"},{"key":"CIT0026","unstructured":"Haute autorit\u00e9 de sant\u00e9. Choix m\u00e9thodologiques pour l\u2019\u00e9valuation \u00e9conomique \u00e0 la HAS. http:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2011-11\/guide_methodo_vf.pdf. Accessed June 15, 2015"},{"key":"CIT0027","unstructured":"Inspection G\u00e9n\u00e9rale des Affaires Sociales. Evaluation m\u00e9dico-\u00e9conomique en sant\u00e9. 2014. http:\/\/www.igas.gouv.fr\/IMG\/pdf\/2014-066R_-_Rapport_DEF.pdf. Accessed June 15, 2015"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit346"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.11.004"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku257"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-016-0894-y"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu128"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis499"},{"key":"CIT0034","unstructured":"Briggs A, University of Oxford. Parametric survival models and decision models: relating continuous hazards to discrete-time transition probabilities. 2004. http:\/\/www.herc.ox.ac.uk\/conferences-and-presentations\/presentationfilelinks\/abw151004. Accessed June 15, 2015"},{"key":"CIT0035","unstructured":"French National Life Tables. French national life tables Eurostat. 2014. http:\/\/ec.europa.eu\/eurostat\/web\/main\/home. Accessed March 16, 2015"},{"key":"CIT0036","unstructured":"Coignard B, H\u00e9bert M, Eckert C, et\u00a0al. Epidemiological and microbiological characteristics of Clostridium difficile infections, France, 2009: a national, multicentre, prospective survey. Abstracts 20th European Congress of Clinical Microbiology and Infectious Diseases; Vienna, Austria; 10-13 April 2010"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2010.03.025"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2174-7"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2015.06.017"},{"key":"CIT0040","unstructured":"L\u2019Assurance Maladie. Tarifs conventionnels des m\u00e9decins g\u00e9n\u00e9ralistes en France m\u00e9tropolitaine, 27 April 2015. http:\/\/www.ameli.fr\/professionnels-de-sante\/medecins\/votre-convention\/tarifs\/tarifs-conventionnels-des-medecins-generalistes\/tarifs-des-medecins-generalistes-en-metropole.php. Accessed June 15, 2015"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-013-0043-y"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-6-89"},{"key":"CIT0043","first-page":"93","volume":"21","author":"Di Bella S","year":"2013","journal-title":"Infez Med"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000473"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1002\/PHAR.1002"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2012.01.004"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu313"},{"key":"CIT0048","unstructured":"Public Health England. Updated guidance on the management and treatment of Clostridium difficile infection. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/321891\/Clostridium_difficile_management_and_treatment.pdf. Accessed July 17, 2015"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis357"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2017.1302946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T19:47:59Z","timestamp":1599421679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2017.1302946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,16]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7,3]]}},"alternative-id":["10.1080\/13696998.2017.1302946"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2017.1302946","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-01-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-02-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-02-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}